LUCIA KRAUS: Open Payments
NPI 1033392899 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,442 in 76 payments from 19 companies in 2025. Trend: 2023 $1,914 · 2024 $2,931 · 2025 $1,442
Food & beverage: $1,442
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $384 |
| ABBVIE INC. | 19 | $228 |
| Novartis Pharmaceuticals Corporation | 5 | $122 |
| Organon LLC | 12 | $113 |
| PFIZER INC. | 4 | $88 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $74 |
| Incyte Corporation | 3 | $68 |
| UCB, Inc. | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| ANI Pharmaceuticals, Inc. | 1 | $35 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, CIBINQO, OPZELURA, Bimzelx, ILUMYA, Rhapsido.
Industry payments across FL — which companies pay providers there.
